Skip to content

Determination of serum CGRP (Calcitonin gene-related peptide) level in patients with Vestibular migraine

Determination of serum CGRP (Calcitonin gene-related peptide) level in patients with Vestibular migraine

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007056
Enrollment
60
Registered
2022-03-04
Start date
2022-02-17
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Jeonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who meet the diagnostic criteria for each disease. Those without a history of other diseases that may cause vestibular dysfunction. Those without other neurological symptoms. A patient who can understand research contents, follow instructions, and can communicate. Those who agreed to participate in the research. 20 years old or older and under 70 years old.

Exclusion criteria

Exclusion criteria: Those who show abnormal findings in neurological examination or neuroimaging study. Those with a history of treatment for other diseases that may cause vestibular dysfunction. There are other clinically serious diseases (cerebrovascular disease, neurodegenerative disease, cardiopulmonary disease, liver disease, kidney disease, hemostatic abnormality, blood disease, malignant tumor, musculoskeletal disease, psychiatric disease, etc.). Those who have difficulty participating. Women of childbearing and pregnant women. Those who do not agree to participate in the research.

Design outcomes

Primary

MeasureTime frame
Determine the difference in serum CGRP level in patients with vestibular migraine and Ménière's disease and vestibular neuronitis.

Secondary

MeasureTime frame
Analyze the clinical factors affecting the difference in serum CGRP level.

Countries

Korea, Republic of

Contacts

Public ContactJin-Ju Kang

Jeonbuk National University Hospital

jinj_k@naver.com+82-63-250-1590

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026